INDEX 



965 



Epinephrin, in Addison's disease, 

 data concerning physiological action 

 of, 307. 



amount of, in suprarenals, in diff- 

 erent conditions, 266. 



and blood sugar content, 157. 



concentration of, in blood plasma of 

 suprarenal veins, 151. 



demonstrated in blood of the adrenal 

 veins, 127. 



by frog perfusion method (in cats 

 and rabbits), 128. 



by rabbit intestine segment 



method (in dogs), 129. 



depressor effects of, 197. 



destruction of, in body, 193. 



differential effects of, in various or- 

 gans, 203. 



on circulation of the brain, 221. 



on circulation of the intestine, 



217. 



on circulation of the kidney, 214. 



on circulation of the limb, 205. 



on circulation of the liver, 208. 



on circulation of the spleen, 212. 



on heart, 222. 



pulmonary circulation, 225. 



distribution of, 93. 



as between the cortex and 



medulla, 190. 



effects of, on arterial system, 188. 



on the circulation, 203. 



of the brain, 221. 



of the heart, 222. 



of the intestine, 217. 



of the kidney, 214, 456. 



of the limb, 205. 



of the liver, 208. 



pulmonary, 225. 



of the spleen, 212. 



of, on heart, 189. 



on metabolism, general, 246. 



sugar, 246. 



on venous pressure, 228. 



toxic, 251. 



functions of, in body, 151. 



and glycosuria, 157. 



history of (Abel), 80, 81. 



indispensability of, 161. 



induced by asphyxia, 174. 

 by excitement, 175. 



by sensory stimulation, evidence 



of, 172. 



location of action of, 252. 



gangliar mechanism, 253. 



myoneural junctions, 252. 



locus of stimulation by, 192. 



in ophthalmology, 804. 



persistence of, in blood-stream, 193. 



Epinephrin, pressor effect of, 191. 

 factors modifying, 230. 



quantitative output of, 131. 

 action on, of lungs, 146. 



atropin, 149. 



curara, 149. 



nicotin, 147, 148. 



physostigmin, 151. 



pilocarpin, 149. 



strychnin, 146, 149. 



for cats (29), under urethane, 



132. 

 control of, by nervous system, 



134. 



abdominal sympathetic, 136. 



afferent paths, 140. 



central nervous mechanism, 



137. 



sensory nerves, 140. 



splanchnic nerve, 134. 



for dogs (17), under morphin and 



ether, 133. 



influence on, of asphyxia, 143. 



for macaque monkeys (2), 134. 



respiratory effects of, 243. 



response to, of alimentary canal, 

 238. 



of bladder, 239. 



of body temperature, 249. 



of bronchioles, 241. 



of genital organs, 240. 



of glands, 243. 



of kidney activity, 244. 



of metabolism, general, 246. 



sugar, 246. 



of muscular activity, 250. 



of pigment cells, 242. 



of the pupils, 237. 



of respiratory system, 243. 



of smooth muscle in skin, 242. 



of sweat glands, 242. 



of ureter, 239. 

 of urethera, 239. 



store of, in suprarenals, 164. 



terminology of, 92. 



use of, in therapy, 943. 



vasoconstrictor effect of, 191. 



problem of, 189. 



vasodilator effects of, Cannon and 

 Lyman (1913), 199. 



characteristic of vasomotor reac- 

 tion to epinephrin, 203. 



Dale (1906), 198. 



Elliott (1905), 198. 



Hartman (1915), 200. 



Hoskins and McClure (1912), 



199. 



indications from observations, 



201. 



